431 related articles for article (PubMed ID: 7567936)
21. Rearrangement and expression of beta-T-cell receptor and immunoglobulin genes in established Ph1 chronic myelogenous leukemia cell lines.
Berenson J; Koeffler HP
Hematol Pathol; 1989; 3(3):125-32. PubMed ID: 2556359
[TBL] [Abstract][Full Text] [Related]
22. [Philadelphia-positive acute mixed leukemia with monosomy 7].
Futaki M; Ito T; Inokuchi K; Yamada T; Ohki I; Kuwabara T; Dan K; Kuriya S; Nomura T; Shinohara T
Rinsho Ketsueki; 1989 Nov; 30(11):1997-2001. PubMed ID: 2558234
[TBL] [Abstract][Full Text] [Related]
23. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
24. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582
[TBL] [Abstract][Full Text] [Related]
26. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of a case of Philadelphia chromosome-positive acute myeloid leukemia.
Yoshida A; Kishi S; Kita K; Kamada N; Nakamura T; Ueda T
Anticancer Res; 1997; 17(1B):625-8. PubMed ID: 9066590
[TBL] [Abstract][Full Text] [Related]
28. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
Laneuville P; Sullivan AK
Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
[TBL] [Abstract][Full Text] [Related]
29. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
30. [i(17q) appearing in acute phase in Ph1-negative, BCR-negative CML].
Uike N; Yamashita S; Obama K; Takahira H; Nakai H; Inazawa J; Umemura T; Akashi K; Kozuru M
Rinsho Ketsueki; 1992 May; 33(5):694-9. PubMed ID: 1630023
[TBL] [Abstract][Full Text] [Related]
31. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
Bock O
Verh Dtsch Ges Pathol; 2007; 91():140-53. PubMed ID: 18314608
[TBL] [Abstract][Full Text] [Related]
32. Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.
Kantarjian HM; Shtalrid M; Kurzrock R; Blick M; Dalton WT; LeMaistre A; Stass SA; McCredie KB; Gutterman J; Freireich EJ
Am J Med; 1988 Nov; 85(5):639-44. PubMed ID: 3189367
[TBL] [Abstract][Full Text] [Related]
33. Use of pulsed field gel electrophoresis to characterize BCR gene involvement in CML patients lacking M-BCR rearrangement.
Min GL; Martiat P; Pu GA; Goldman J
Leukemia; 1990 Sep; 4(9):650-6. PubMed ID: 2395384
[TBL] [Abstract][Full Text] [Related]
34. High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements.
Pelz AF; Kröning H; Franke A; Wieacker P; Stumm M
Ann Hematol; 2002 Mar; 81(3):147-53. PubMed ID: 11904740
[TBL] [Abstract][Full Text] [Related]
35. [Cytogenetic and molecular aspects of Ph-positive leukemia].
Misawa S; Nishigaki H
Rinsho Ketsueki; 1991 Apr; 32(4):313-8. PubMed ID: 2067072
[TBL] [Abstract][Full Text] [Related]
36. Molecular diagnosis of chronic myeloid leukemia using a 3'bcr probe.
Berthéas MF; Vindimian M; Ollagnon G; Pomier G; Jaubert J; Vasselon C; Reynaud J; Heally JC; Le Petit JC; Brizard CP
Nouv Rev Fr Hematol (1978); 1989; 31(6):393-5. PubMed ID: 2616268
[TBL] [Abstract][Full Text] [Related]
37. Minor BCR (m-bcr) rearrangements may appear in major BCR (M-bcr)-positive CML cases.
Karlic H; Grill R; Schlögl E
Hematol Pathol; 1992; 6(4):203-7. PubMed ID: 1362728
[TBL] [Abstract][Full Text] [Related]
38. [Myelodysplastic syndrome in a child which developed into megakaryocytic leukemia with late appearing Ph1 chromosome and rearrangement of breakpoint cluster region].
Inaba T; Hayashi Y; Hosoya S; Hanada R; Yamamoto K; Nishida T; Nakamura K; Mizutani S; Sugita K; Nakazawa S
Rinsho Ketsueki; 1990 Jul; 31(7):994-8. PubMed ID: 2214196
[TBL] [Abstract][Full Text] [Related]
39. BCR rearrangements in Ph positive chronic myelocytic leukemia.
Deng DS; Yang AD; Gong WL; Fei HB; Liu SM
Chin Med J (Engl); 1991 Aug; 104(8):658-63. PubMed ID: 1680611
[TBL] [Abstract][Full Text] [Related]
40. Identical utilization of T-cell receptor gene regions in B-lymphoid blast crisis of chronic myeloid leukemia and B-precursor acute lymphoblastic leukemia.
di Celle PF; Carbone A; Lo Coco F; Guerrasio A; Diverio D; Rosso C; Lopez M; Saglio G; Foà R
Leukemia; 1991 May; 5(5):366-72. PubMed ID: 1827853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
